Author

D. M. Wolf

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1

Frequent Co-Authors

A. Basu· 1 shared A. Demichele· 1 shared A. J. Johnson· 1 shared A. K. Kondadi· 1 shared A. Prahallad· 1 shared A. Ruiz-Saenz· 1 shared A. S. Reichert· 1 shared B. Hann· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Basu

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Brain resident memory T cells rapidly expand and initiate neuroinflammatory responses following CNS injury and viral infection

K. Ayasoufi, D. M. Wolf, S. L. Namen, Z. P. Tritz, F. Jin, C. K. Pfaller, E. N. Goddery, C. E. Fain, L. R. Gulbicki, R. H. Khadka, L. T. Yokanovich, M. J. Hansen, A. J. Johnson

This study identifies antigen-specific brain-resident memory T cells that expand rapidly after CNS injury or viral infection and induce neuroinflammation and peripheral immune suppression.

Brain, Behavior, and Immunity · Aug 1, 2023Peer-reviewedImmunology

Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes

K. Yu, A. Basu, C. Yau, D. M. Wolf, H. Goodarzi, S. Bandyopadhyay, J. E. Korkola, G. L. Hirst, S. Asare, I-SPY 2 TRIAL, A. Demichele, N. Hylton, D. Yee, L. Esserman, L. van 't Veer, M. Sirota

This study uses computational drug repositioning to identify agents that can sensitize drug-resistant breast tumors, finding fulvestrant effective across multiple treatment and receptor subtypes.

bioRxiv · Mar 30, 2023Cell Biology

A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colorectal tumors

A. Ruiz-Saenz, C. E. Atreya, C. Wang, B. Pan, C. A. Dreyer, D. Brunen, A. Prahallad, D. P. Munoz, D. J. Ramms, V. Burghi, D. S. Spassov, E. Fewings, Y. C. Hwang, C. Cowdrey, C. Moelders, , J.-P. Coppe

This study identifies a SRC-relayed COX2-inflammatory program that drives resistance to BRAF/MEK/EGFR therapies in BRAFV600E colorectal tumors and shows that co-targeting COX2 improves therapeutic outcomes.

bioRxiv · Oct 20, 2022 · PreprintCancer Biology

Cristae undergo continuous cycles of fusion and fission in a MICOS-dependent manner

A. K. Kondadi, R. Anand, S. Haensch, J. Urbach, T. Zobel, D. M. Wolf, M. Segawa, M. Liesa, O. S. Shirihai, S. Weidtkamp-Peters, A. S. Reichert

The paper uses live-cell imaging to show mitochondrial cristae undergo continuous fusion and fission, dependent on MIC13, with dynamics similar to crista junctions.

bioRxiv · May 30, 2019Cell Biology